Vialwirebiotech, curated
October 1, 2026, 3:04 AM
August 14, 2026
- 2:30 AM · Science (News)2:30 AMNIH is ending a key grant for budding clinical researchers — Science (News)
August 13, 2026
- 12:05 PM · BioPharma Dive12:05 PMNew Taiho, Cullian data heats up lung cancer drug battle — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMAntibody fever in Indupro’s $77M series B, Boulevard‘s $65M launch — BioWorld
- 12:00 PM · BioWorld12:00 PMSilence draws upsized $175M after divesiran’s phase II PV win — BioWorld
- 12:00 PM · BioWorld12:00 PMStaar wars end, PTC victor; Fabry drug Lukes viable — BioWorld
- 12:00 PM · BioWorld12:00 PMWomen's health funding up, but only a drop in an ocean of opportunity — BioWorld
- 9:26 AM · Drug Discovery World9:26 AMCN Bio awarded Innovate UK grant to reduce animal testing — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMInsilico Medicine nominates ISM-0900 as cardiovascular candidate — BioWorld
- 9:00 AM · BioWorld9:00 AMChina NMPA clears Ark’s AK-0406 for clinic for influenza prophylaxis — BioWorld
- 6:20 AM · Pharmaceutical Technology6:20 AMRepligen’s deal for BioLife Solutions indicates shift to manufacturing integration — Pharmaceutical Technology
- 5:06 AM · Pharmaceutical Technology5:06 AMRemepy secures $36m funding for hybrid drug pipeline expansion — Pharmaceutical Technology
- 4:10 AM · Drug Discovery World4:10 AMRadiotherapeutic study shows low exposure to healthy organs — Drug Discovery World
August 12, 2026
- 4:47 PM · Bloomberg — Technology4:47 PMFermi Names McIntire CEO Four Months After Ousting Co-Founder — Bloomberg — Technology
- 4:46 PM · STAT News4:46 PMTalks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says — STAT News
- 12:00 PM · BioWorld12:00 PMVogenx prices $81M IPO to advance metabolic pipeline — BioWorld
- 12:00 PM · BioWorld12:00 PMVeloxis to pay more than $46M to resolve kickback charges — BioWorld
- 11:19 AM · BioPharma Dive11:19 AMLilly files six lawsuits in bid to shut down ‘black market’ for retatrutide — BioPharma Dive
- 9:12 AM · PharmaVoice9:12 AMFormation Bio taps Biogen, Pfizer alum to tackle R&D’s ‘boring middle’ — PharmaVoice
- 9:00 AM · BioWorld9:00 AMXilio’s XTX-501 gains IND clearance for solid tumors — BioWorld
- 9:00 AM · BioWorld9:00 AMAlmirall and Crystalo partner in dermatological drug discovery — BioWorld
- 9:00 AM · Labiotech (EU)9:00 AMUCB’s pipeline strategy in 2026: Doubling down on immunology and neurology — Labiotech (EU)
- 9:00 AM · BioWorld9:00 AMGilead exercises option for Macrogenics solid tumor program — BioWorld
- 9:00 AM · BioWorld9:00 AMNIAID contract supports Ceramedix’s gastrointestinal ARS program — BioWorld
- 9:00 AM · BioWorld9:00 AMSeries A financing at Beyang Therapeutics — BioWorld
- 9:00 AM · BioWorld9:00 AMSuzhou Genhouse Bio discovers new DHX9 inhibitors — BioWorld
- 8:01 AM · STAT News
- 7:40 AM · SCMP — Tech7:40 AMWill Trump’s proposed drug tariffs end India’s reign as ‘pharmacy of the world’? — SCMP — Tech
- 6:19 AM · Pharmaceutical Technology6:19 AMInvestigational CRISPR therapy succeeds in patient with drug-resistant E. Coli — Pharmaceutical Technology
- 6:04 AM · Pharmaceutical Technology6:04 AMEpicrispr, Vaderis secure pivotal study funding for rare disease assets — Pharmaceutical Technology
- 4:30 AM · STAT News
- 4:20 AM · Pharmaceutical Technology4:20 AMAlfasigma signs agreement to acquire Nordic Group — Pharmaceutical Technology